IBM And Microsoft Partnership Accelerates Sustainable Cloud Modernization

A global fast-moving consumer goods (FMCG) enterprise needed to modernize its product portfolio, focusing on high-growth categories like pet care, coffee and consumer health. Its aggressive sustainability goals included

A global fast-moving consumer goods (FMCG) enterprise needed to modernize its product portfolio, focusing on high-growth categories like pet care, coffee and consumer health. Its aggressive sustainability goals included achieving net zero emissions by 2050, making all packaging reusable or recyclable by 2025 and investing more than USD 3 billion globally over several years to drive momentum. Along the way, it needed to transform its organizational footprint, technology architecture and workplace culture—all sustainably.

IBM Consulting™ helped the customer modernize its architecture for a heavily used business-to-business conversational AI app. IBM’s recommendations included API-specific improvements, bot UX optimization, workflow optimization, DevOps microservices and design consideration, and best practices for Azure manage services. After getting familiar with the app architecture, priorities and requirements, IBM provided a detailed trade-offs analysis, including improvement options and security and cost implications.

The need to digitally transform touches every organization, in every industry. As a result, increasing numbers of organizations are migrating their information and communication technology (ICT) infrastructures to the public cloud, shifting workloads from on-premises to remote data centers and modernizing their application estates. While this trend is driving growth in the global cloud market, it’s also drawing increased scrutiny to the environmental impacts of data centers.

Total
0
Shares
Related Posts
Read More

SomaLogic Expands Agreement With Novo Nordisk To 2025, Will Expand Its Use Of The SomaScan Proteomics Platform In Drug R&D Novo Nordisk Will Also Use SomaLogic’s SomaSignal Tests For Investigations Into Cardiometabolic And Other Diseases

SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk. As part of the agreement, which now extends into the

NVO